Achievwin
★    

US,
2021-07-06 16:37
(1023 d 01:40 ago)

Posting: # 22459
Views: 1,720
 

 BE for a drug dosed on body weight [Study Per­for­mance]

Has anyone have experience in designing bioequivalence trial for a (oncology or other) drug which dosing varies with body weight (varying doses)? How do you present PK across subjects receiving varying doses (dose normalize to a bench mark dose? or since BE is based on ratio it has no impact?)

Thanks for any feed back:-|
dshah
★★  

India/United Kingdom,
2021-07-17 13:46
(1012 d 04:31 ago)

@ Achievwin
Posting: # 22475
Views: 1,299
 

 BE for a drug dosed on body weight

Dear Achievwin!
If the study is crossover, then the dose administered would generally be same for that subject and thus we could assume that it would not have any impact.
Regards,
Dshah
UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,659 registered users;
70 visitors (0 registered, 70 guests [including 3 identified bots]).
Forum time: 18:18 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5